Average Co-Inventor Count = 6.20
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Laboratoire Francais Du Fractionnement Et Des Biotechnologies (13 from 85 patents)
2. Lfb Biotechnologies (5 from 10 patents)
3. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)
4. Biotest Pharma Gmbh (1 from 23 patents)
5. Association Pour L'essor De La Transfusion Sanguine Dans La Region Du (1 from 7 patents)
6. Labortoire Francais Du Fractionnement Et Des Biotechnologies (1 from 1 patent)
7. Laboratoire Francais Du Fractionnement Et Des Biotechnolgies (lfb) (1 from 1 patent)
21 patents:
1. 10081683 - Monoclonal antibodies with enhanced ADCC function
2. 9879089 - Use of ADCC-optimized antibodies for treating low-responder patients
3. 9718890 - Monoclonal antibodies with enhanced ADCC function
4. 9718889 - Monoclonal antibodies with enhanced ADCC function
5. 9708409 - Monoclonal antibodies with enhanced ADCC function
6. 9109020 - Use of ADCC-optimized antibodies for treating weak patients
7. 8685725 - Monoclonal antibodies with enhanced ADCC function
8. 8501171 - Use of ADCC-optimized antibodies for treating weak patients
9. 8409572 - Monoclonal antibodies with enhanced ADCC function
10. 8357370 - Anti-D monoclonal antibodies
11. 8178093 - Method for treating infectious disease using monoclonal antibodies
12. 8153124 - Method for treating cancer using monoclonal antibodies
13. 8124078 - Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
14. 7931895 - Monoclonal antibodies with enhanced ADCC function
15. 7790399 - Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors